PBR Life Sciences, a leader in healthcare big data, has raised $1 million in funding, highlighting the significance of its innovative approach to the field.
Startup and Growth of PBR Life Sciences
Founded by Ayodeji Alaran, a graduate of the University of Lagos and London Business School, who previously worked for GSK, Pfizer, and AstraZeneca. The company shifted its focus to big data in 2021, identifying major industry gaps.
Company Achievements and Plans
Over the past year, PBR Life Sciences increased its revenue by 200%, and its database now includes over 50 million pharmaceutical products. The company provides access to high-quality data for African, European, American, and Asian markets. Expansion into Ghana and Kenya is planned.
Reasons and Importance of Investment
This investment will allow the company to scale its platform in Nigeria and support growth in other African markets. The company aims to become a leading data provider in emerging markets by 2030.
Investment in PBR Life Sciences confirms the importance of health data innovation and the potential of companies in emerging markets.
